Literature DB >> 32341634

Behavioral Interventions in Multiple Sclerosis.

Aaron P Turner1, Lindsey M Knowles1.   

Abstract

IMPORTANCE: Multiple sclerosis (MS) is a complex and unpredictable neurologic disease affecting nearly 1 million people in the US. People with MS commonly experience multiple physical and psychological symptoms such as depression, anxiety, stress, fatigue, and pain that impact functioning and quality of life. Subsequently, living with MS requires routine management of MS symptoms, adaptation to challenges, and engagement in health behaviors to promote well-being over time. OBSERVATIONS: There is considerable evidence that behavioral interventions that increase cognitive and/or behavioral skills to address the challenges of day-to-day life with MS can promote resilience and reduce overall distress associated with this chronic and unpredictable disease. Brief group-based cognitive-behavioral therapy (CBT) and CBT-based interventions (eg, self-management) have been shown to reduce symptoms of depression, anxiety, stress, fatigue, and pain in people with MS, including via telehealth delivery. Likewise, mindfulness-based interventions have been shown to improve depression, anxiety, stress, fatigue, and quality of life in people with MS. Behavioral interventions also have been shown to improve health behaviors such as physical activity and adherence to disease modifying therapies in MS. Unlike other treatment options, behavioral interventions can be delivered in various formats (eg, in-person, telehealth), are time-limited, and cause few (if any) undesirable systemic side effects.
CONCLUSIONS: Behavioral intervention is an integral component of interprofessional care and key aspect of living well with MS.
Copyright © 2020 Frontline Medical Communications Inc., Parsippany, NJ, USA.

Entities:  

Year:  2020        PMID: 32341634      PMCID: PMC7182244     

Source DB:  PubMed          Journal:  Fed Pract        ISSN: 1078-4497


  63 in total

Review 1.  Fatigue in multiple sclerosis: definition, pathophysiology and treatment.

Authors:  Lauren B Krupp
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

2.  Prevalence and concurrence of anxiety, depression and fatigue over time in multiple sclerosis.

Authors:  B Wood; I A F van der Mei; A-L Ponsonby; F Pittas; S Quinn; T Dwyer; R M Lucas; B V Taylor
Journal:  Mult Scler       Date:  2012-06-22       Impact factor: 6.312

3.  Improving fatigue and depression in individuals with multiple sclerosis using telephone-administered physical activity counseling.

Authors:  Aaron P Turner; Narineh Hartoonian; Alicia P Sloan; Marisa Benich; Daniel R Kivlahan; Christina Hughes; Abbey J Hughes; Jodie K Haselkorn
Journal:  J Consult Clin Psychol       Date:  2016-02-25

4.  Suicidal ideation in multiple sclerosis.

Authors:  Aaron P Turner; Rhonda M Williams; James D Bowen; Daniel R Kivlahan; Jodie K Haselkorn
Journal:  Arch Phys Med Rehabil       Date:  2006-08       Impact factor: 3.966

5.  A pilot randomised controlled trial of an Internet-based cognitive behavioural therapy self-management programme (MS Invigor8) for multiple sclerosis fatigue.

Authors:  Rona Moss-Morris; Paul McCrone; Lucy Yardley; Kirsten van Kessel; Gary Wills; Laura Dennison
Journal:  Behav Res Ther       Date:  2012-03-13

6.  Anxiety and depression in multiple sclerosis. A comparative population-based study in Nord-Trøndelag County, Norway.

Authors:  Ole-Petter Dahl; Eystein Stordal; Stian Lydersen; Rune Midgard
Journal:  Mult Scler       Date:  2009-11-13       Impact factor: 6.312

7.  Multi-centre parallel arm randomised controlled trial to assess the effectiveness and cost-effectiveness of a group-based cognitive behavioural approach to managing fatigue in people with multiple sclerosis.

Authors:  Peter W Thomas; Sarah Thomas; Paula Kersten; Rosemary Jones; Alison Nock; Vicky Slingsby; Colin Green; Roger Baker; Kate Galvin; Charles Hillier
Journal:  BMC Neurol       Date:  2010-06-16       Impact factor: 2.474

8.  The effects of home-based resistance exercise on balance, power, and mobility in adults with multiple sclerosis.

Authors:  Louisa S DeBolt; Jeffrey A McCubbin
Journal:  Arch Phys Med Rehabil       Date:  2004-02       Impact factor: 3.966

9.  Mood and anxiety disorders in patients with multiple sclerosis.

Authors:  Faruk Uguz; Zehra Akpinar; Ishak Ozkan; Serhat Tokgoz
Journal:  Int J Psychiatry Clin Pract       Date:  2008       Impact factor: 1.812

Review 10.  The incidence and prevalence of psychiatric disorders in multiple sclerosis: a systematic review.

Authors:  Ruth Ann Marrie; Stephen Reingold; Jeffrey Cohen; Olaf Stuve; Maria Trojano; Per Soelberg Sorensen; Gary Cutter; Nadia Reider
Journal:  Mult Scler       Date:  2015-01-12       Impact factor: 6.312

View more
  1 in total

1.  Distress and risk perception in people living with multiple sclerosis during the early phase of the COVID-19 pandemic.

Authors:  Kevin N Alschuler; Michelle K Roberts; Tracy E Herring; Dawn M Ehde
Journal:  Mult Scler Relat Disord       Date:  2020-11-05       Impact factor: 4.339

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.